Gland Pharma's Q1FY24 consolidated PAT up QoQ at Rs. 194.10 crores

Gland Pharma Limited has reported Consolidated financial results for the period ended June 30, 2023.

Financial Results (Q1 FY2024) - QoQ Comparison

The company has reported total income of Rs. 1246.235 crores during the period ended June 30, 2023 as compared to Rs. 823.950 crores during the period ended March 31, 2023.

The company has posted net profit / (loss) of Rs. 194.102 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs. 78.683 crores for the period ended March 31, 2023.

The company has reported EPS of Rs. 11.78 for the period ended June 30, 2023 as compared to Rs. 4.78 for the period ended March 31, 2023.

Financials	Q1 FY2024	Q4 FY2023	% Change
Total Income	₹ 1246.235 crs	₹823.950 crs	51.25%
Net Profit	₹194.102 crs	₹78.683 crs	146.69%
EPS	₹11.78	₹4.78	146.44%

Financial Results (Q1 FY2024) - YoY Comparison

The company has reported total income of Rs. 1246.235 crores during the period ended June 30, 2023 as compared to Rs.931.289 crores during the period ended June 30, 2022.

The company has posted net profit / (loss) of Rs.194.102 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs.229.169 crores for the period ended June 30, 2022.

The company has reported EPS of Rs.11.78 for the period ended June 30, 2023 as compared to Rs.13.92 for the period ended June 30, 2022.

Financials	Q1 FY2024	Q1 FY2023	% Change
Total Income	₹ 1246.235 crs	₹931.289 crs	33.82%
Net Profit	₹194.102 crs	₹229.169 crs	-15.30%
EPS	₹11.78	₹13.92	-15.37%

Shares of Gland Pharma Limited was last trading in BSE at Rs. 1343.85 as compared to the previous close of Rs. 1335.05. The total number of shares traded during the day was 37067 in over 3142 trades.

The stock hit an intraday high of Rs. 1377.45 and intraday low of 1303.15. The net turnover during the day was Rs. 49693127.00.

Source : Equity Bulls

Keywords

GlandPharma Q1FY24 ResultUpdate